Activist Palliser Pushes Chemring Breakup, Eyes £730M Roke Sale
CMGMF has more than doubled off its 52-week low of $1.69.
Summary
Palliser Capital, the London activist led by former Elliott executive James Smith, has sent a letter to Chemring's board demanding a strategic review and a possible sale of its electronic warfare unit, Roke. Palliser holds roughly a 3% stake and wants to meet chair Tony Wood. The letter argues Roke could fetch £600mn to £730mn as a standalone trade sale, against a total company market value of about £1.4bn — meaning the unit alone could be worth a large share of the whole. Palliser's core complaint is that Chemring has produced the weakest shareholder returns in its peer group through the largest rearmament cycle since WWII, with no earnings growth, and that separating Roke would let management focus on the more attractive energetics business. Shares rose 2.3% in London on the FT report. Chemring said it welcomes shareholder engagement but declined to comment on speculation. The stake is small, so the outcome hinges on whether other holders back the breakup case and whether the board agrees to a formal review.
At the time of this announcement, CMGMF was trading at $7.20 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $1.69 to $8.59. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.